Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molecular Partners Ag (MOLN) Shares Issued (2021 - 2025)

Historic Shares Issued for Molecular Partners Ag (MOLN) over the last 5 years, with Q3 2025 value amounting to -$1248.8.

  • Molecular Partners Ag's Shares Issued fell 302425.86% to -$1248.8 in Q3 2025 from the same period last year, while for Sep 2025 it was $19.8 million, marking a year-over-year increase of 5652842.56%. This contributed to the annual value of $19.7 million for FY2024, which is 5630575.98% up from last year.
  • Latest data reveals that Molecular Partners Ag reported Shares Issued of -$1248.8 as of Q3 2025, which was down 302425.86% from $1206.7 recorded in Q2 2025.
  • Molecular Partners Ag's Shares Issued's 5-year high stood at $57.5 million during Q2 2021, with a 5-year trough of -$57.1 million in Q3 2021.
  • For the 5-year period, Molecular Partners Ag's Shares Issued averaged around $4.0 million, with its median value being $55.3 (2021).
  • Within the past 5 years, the most significant YoY rise in Molecular Partners Ag's Shares Issued was 10922366.39% (2025), while the steepest drop was 302425.86% (2025).
  • Quarter analysis of 5 years shows Molecular Partners Ag's Shares Issued stood at $55.8 million in 2021, then plummeted by 99.54% to $259249.0 in 2022, then plummeted by 86.53% to $34915.3 in 2023, then soared by 56597.87% to $19.8 million in 2024, then tumbled by 100.01% to -$1248.8 in 2025.
  • Its last three reported values are -$1248.8 in Q3 2025, $1206.7 for Q2 2025, and $1.11 during Q1 2025.